The inhibition of GSK‐3β via phosphorylation has been correlated with neuroprotection in brain injury (Leeds et al., 2014), and GSK‐3β is implicated as a factor in Alzheimer's and other neurodegenerative diseases (Grigor'yan, 2014). The gene discussed is GSK3B; the disease is neurodegenerative disease.